Provider
QP10-21 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 100-150 mg, 133-200 mg, and 167-250 mg
Program effective Date: Feb 10, 2021
Documents & Forms Results
Displaying 2151 - 2160 of 3102 results
Provider
QP12-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2021
Program effective Date: Feb 10, 2021
Provider
P6-21 New Medical Policy IV-168: Hysterectomy Surgery for Non-Malignant Conditions
Program effective Date: Feb 01, 2021
Provider
P11-21 Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Program effective Date: Feb 01, 2021
Provider
P8-21 New Reimbursement Policy – Mohs-Micrographic Surgery
Program effective Date: Feb 01, 2021
Provider
P93R1-20 Update: Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Feb 01, 2021
Provider
P9-21 New Claim Edits for Professional Lab Claims Missing Required Data
Program effective Date: Feb 01, 2021
Provider
P10-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective April 5, 2021
Program effective Date: Feb 01, 2021
Provider
2021 February Bulletins
Program effective Date: Feb 01, 2021
Provider
P12-21 Early Intensive Developmental and Behavioral Intervention (EIDBI) Service Authorization for Minnesota Health Care Programs
Program effective Date: Feb 01, 2021